Increased production of inflammatory cytokines in patients with silent myocardial ischemia

Journal of the American College of Cardiology

Volumn 38, Issue 7, 2001, Pages 1895-1901

  Mazzone, Antonino ^a,d   Cusa, Chiara ^a   Mazzucchelli, Iolanda ^a   Vezzoli, Monia ^a   Ottini, Elena ^a   Pacifici, Roberta ^b   Zuccaro, Piergiorgio ^b   Falcone, Colomba ^c  

^a Hospital of Legnano   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d Legnano Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ANTIGEN EXPRESSION; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE TEST; FLOW CYTOMETRY; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYMPTOMATOLOGY;

AGED; ANGINA PECTORIS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CYTOKINES; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FLOW CYTOMETRY; HUMANS; MACROPHAGE-1 ANTIGEN; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PAIN THRESHOLD;

EID: 0035203594     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01660-6     Document Type: Article

References (56)

1. Mechanisms of disease: Atherosclerosis and inflammatory disease
2. New insights into the pathogenesis and prevention of acute coronary syndromes
3. Influence of opiate system in pain transmission during angina pectoris
4. Correlation between beta-endorphin plasma levels and anginal symptoms in patients with coronary artery disease
5. Silent ischemia: A hypothetical mechanism
6. Dental pain threshold and angina pectoris in patients with coronary artery disease
7. The importance of generalized defective perception of painful stimuli as a cause of silent myocardial ischemia in chronic stable angina pectoris
8. Beta-endorphins during coronary angioplasty in patients with silent or symptomatic myocardial ischemia
9. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease
10. Clinical and angiographic correlates of leukocyte activation in unstable angina
11. Increased expression of CD11b/CD18 on phagocytes in ischaemic disease: A bridge between inflammation and coagulation
12. Cytokine modulation of LDL oxidation by activated human monocytes
13. Relation of inflammation to vascular function in patients with coronary heart disease
14. Plasma concentration of IL6 and the risk of future myocardial infarction among apparently healthy men
15. Circulating markers of inflammation for vascular risk prediction
16. Cytokine and soluble adesion molecules. Possible manifestation of atherosclerotic response in atherosclerosis
17. Leukocyte CD11/CD18 integrins: Biological and clinical relevance
18. Cytokines, nerve growth factor and inflammatory hyperalgesia: The contribution of tumor necrosis factor-alpha
19. Characterization of cytokine-induced hyperalgesia
20. Can inflammation relieve pain?
21. Increased expression of peripheral benzodiazepine receptors on leukocytes in silent myocardial ischemia
22. Peptide opioids and morphine effects on inflammatory process
23. Interaction between morphine and granulocyte aggregation in myocardial ischemia
24. Opioid and opiate immunoregulatory processes
25. Mechanism of disease. The control of pain in peripheral tissue by opioids
26. Enkelytin and opioid peptide association in invertebrates and vertebrates: Immune activation and pain
27. Pain control by immune-derived opioids
28. Morphine synergizes with lipopolysaccharide in a chronic endotoxemia model
29. Sodium ions modulate differentially the effect of a benzodiazepine agonist on rat spinal μ, δ and κ opioid receptors
30. Potential role of peripheral benzodiazepine receptors in inflammatory responses
31. Modulation of tumor necrosis factor-α, interleukin-1β, interleukin-6, interleukin-8, and granulocyte/macrophage colony-stimulating factor expression in human monocytes by an endogenous anxiogenic benzodiazepine ligand, triakontatetraneuropeptide: Evidence for a role of prostaglandins
32. Enigma of peripheral benzodiazepine receptor
33. Inflammation and acute coronary syndrome
34. Monoclonal T-cell activation and plaque instability in acute coronary syndromes
35. Plasma level of interleukin-2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease
36. Beta-endorphin in the immune system: A role at last?
37. Involvement of the inflammatory cytokines TNF-α IL-1-beta and IL-6 but not IL-8 in the developement of heat hyperalgesia: Effects of heat-evoked CGRP release from rat skin
38. Intracerebrovascular injection of interleukin-1-beta enhances nociceptive neuronal responses of the trigeminal nucleus caudalis in rats
39. Biphasic effects of intracerebroventricular IL-1-beta on mechanical nociception in the rat
40. Intracerebrovascular injection of IL-1-beta induces hyperalgesia in rats
41. Spinal cord SP release and hyperalgesia in monoarthritic rats: Involvement of the GABA-B receptors system
42. Cytokine-mediated inflammatory hyperalgesia limited by IL 1 receptor antagonist
43. Nociceptive and inflammatory effects of subcutaneous TNF-α
44. The effect of pentoxifiline on post-injury hyperalgesia in rats and postoperative pain in patients
45. Cytokine involvement in dynorphin-induced allodynia
46. Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneural TNF-alpha expression
47. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10
48. IL-10 reduces the endotoxin-induced hyperalgesia in mice
49. Modulation of the immune response by TGF-beta
50. Transforming growth factor-beta (TGF-beta)
51. Regulation of the immune responses by TGF-beta
52. Cytokine-mediated inflammatory hyperalgesia limited by IL4
53. NF-kappa B: A crucial transcription factor for glial and neuronal cell function
54. Function and activation of NF-kappa B in the immune system
55. NF-κB, nitric oxide and opiate signaling
56. Regulation of NF-kappa B activity in rat dorsal foot ganglia and PC12 cells by tumor necrosis factor and nerve growth factor